These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22932293)

  • 1. [Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture].
    Hayakawa N; Suzuki A
    Clin Calcium; 2012 Sep; 22(9):1383-90. PubMed ID: 22932293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes and osteoporosis].
    Ferrari S
    Rev Med Suisse; 2013 Jun; 9(390):1256, 1258-9. PubMed ID: 23821843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic therapy effects on bone metabolism and fracture risk.
    Montagnani A; Gonnelli S
    Diabetes Obes Metab; 2013 Sep; 15(9):784-91. PubMed ID: 23368527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone as a target of type 2 diabetes treatment.
    Lecka-Czernik B
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1085-90. PubMed ID: 19777397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin-based therapy: how do incretin mimetics and DPP-4 inhibitors fit into treatment algorithms for type 2 diabetic patients?
    Nauck M; Smith U
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):513-23. PubMed ID: 19748068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 inhibitors: from sitagliptin monotherapy to the new alogliptin-pioglitazone combination therapy.
    Argyrakopoulou G; Doupis J
    Adv Ther; 2009 Mar; 26(3):272-80. PubMed ID: 19259628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors.
    Mathieu C; Bollaerts K
    Int J Clin Pract Suppl; 2007 Aug; (154):29-37. PubMed ID: 17593275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.
    Green JB
    Postgrad Med; 2012 Jul; 124(4):54-61. PubMed ID: 22913894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and bone fragility: a dangerous liaison.
    Conti F; Wolosinska DT; Pugliese G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S39-41. PubMed ID: 23907773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes, thiazolidinediones: bad to the bone?
    Watts NB; D'Alessio DA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3276-8. PubMed ID: 16960122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antidiabetic drugs and their effect on bone].
    Jackuliak P; Kužma M; Payer J
    Vnitr Lek; 2017; 63(9):609-616. PubMed ID: 29120659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antidiabetic treatment on bone.
    Jackuliak P; Kužma M; Payer J
    Physiol Res; 2019 Nov; 68(Suppl 2):S107-S120. PubMed ID: 31842574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metabolism in type 2 diabetes and role of thiazolidinediones.
    Vestergaard P
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):125-31. PubMed ID: 19300092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk associated with common medications used in treating type 2 diabetes mellitus.
    Wolverton D; Blair MM
    Am J Health Syst Pharm; 2017 Aug; 74(15):1143-1151. PubMed ID: 28743778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.